Latanoprostene bunod ophthalmic solution 0.024%.

Latanoprostene bunod is thought to lower intraocular pressure by increasing outflow of aqueous humor through both the trabecular meshwork and uveoscleral routes. Intraocular pressure is a major modifiable risk factor for glaucoma progression. Reduction of intraocular pressure reduces risk of glaucomatous visual field loss.

Is used to lower intraocular (eye) pressure in patients with open-angle glaucoma or ocular hypertension